Direct oral anticoagulant therapy reduces primary outcomes in patients with atrial fibrillation and intermediate stroke risk
Blood Thinners Cut Stroke Risk for Some Heart Rhythm Patients
This trial evaluated the impact of direct oral anticoagulant therapy on patients with atrial fibrillation and an intermediate risk of stroke…
For people with atrial fibrillation and moderate stroke risk, blood thinners lowered the chance of stroke, bleeding, or heart-related death.
Impact of Infarct Volume on Safety and Efficacy of Early DOAC Initiation
Trial shows early blood thinners help stroke patients with heart issues
This large-scale trial confirms that early DOAC initiation remains safe and effective regardless of the initial ischemic stroke infarct size…
Early use of blood thinners after a stroke may improve outcomes for patients with atrial fibrillation, regardless of the size of the brain i…
Evaluating Safety and Efficacy of Shortened Dual Antithrombotic Therapy in Atrial Fibrillation
Short dual therapy may reduce bleeding for heart patients
A randomized trial demonstrates that a 1-month dual therapy period significantly reduces bleeding risks without compromising efficacy.
A new trial suggests that a shorter period of dual blood thinners can lower bleeding risks for patients with atrial fibrillation and heart i…